The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Pfizer
A multicenter, open label, phase II study to assess the efficacy and safety of APO866 in the treatment of patients with refractory or relapsed cutaneous T-cell lymphoma.
 
Simone M. Goldinger
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche Pharma AG
 
Sharon Gobbi
Travel, Accommodations, Expenses - St. Jude Medical (I)
 
Michelle Ding
No Relationships to Disclose
 
Anna Lisa Frauchiger
Travel, Accommodations, Expenses - Amgen
 
Regina Fink-Puches
No Relationships to Disclose
 
Claus-Detlev Klemke
Consulting or Advisory Role - Teva
Travel, Accommodations, Expenses - Cephalon; Johnson & Johnson; Teva; Therakos
 
Brigitte Dréno
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
 
Martine Bagot
No Relationships to Disclose
 
Chalid Assaf
Consulting or Advisory Role - Affimed Therapeutics; Amgen; Novartis; Roche Pharma AG; Teva
 
Reinhard Dummer
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche